Further studies are needed to determine whether these adipokines could be used as additional markers for insulin sensitivity and lipid profile and whether they might play a role in the pathogenesis of PCOS, in which the risks of metabolic cardiovascular risks are increased. The gene discussed is INS; the disease is polycystic ovary syndrome.